Navigation Links
New criteria for measuring tumor size and progression will help ease workloads in clinical trials
Date:1/19/2009

The first, formal revision of specific guidelines, known as RECIST, used by clinicians to measure tumour size and response to treatment, has been published today (Tuesday 20 January) in a special issue of the European Journal of Cancer [1]. The authors say that the revisions will ease the workload involved in running clinical trials, without compromising study outcomes.

RECIST (Response Evaluation Criteria in Solid Tumours) were first published in 2000 and are used by investigators in phase II and phase III clinical trials of new anti-cancer drugs as a way of measuring the efficacy of the treatment. Tumour shrinkage (objective response) and time to the development of disease progression are both important endpoints in trials, and, increasingly in recent years, trials have been using time to progression (or progression-free survival) as their main endpoint on which to base conclusions about the efficacy of a drug.

The new RECIST (RECIST 1.1 to distinguish them from the original RECIST) answer some of the questions and issues that have arisen since 2000 as a result of changing methodologies and available treatments.

Professor Jaap Verweij (Erasmus University Medical Centre, The Netherlands), the EJC's clinical oncology editor and a co-editor of the special issue on RECIST, said: "This special issue is very important for the cancer community as the updated criteria will affect all clinicians who are running clinical cancer trials. RECIST 1.1 describes a standard approach to solid tumour measurement and definitions for objective assessment of change in tumour size for use in adult clinical trials."

Co-editor, Professor Elizabeth Eisenhauer (National Cancer Institute of Cancer, Ontario, Canada), stressed that the goal of developing RECIST 1.1 was to improve the consistency and standardisation of trials. "Drug development and clinical cancer research is a global enterprise. The more consistent we are in describing what we have seen
'/>"/>

Contact: Emma Mason (media enquiries only)
wordmason@mac.com
44-077-112-96986
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. New appropriate use criteria guide treatment of patients with heart blockage
2. Eligibility criteria contribute to racial disparities in hospice use
3. New Criteria Could Expand Number of Liver Transplant Candidates
4. How Patients Can Meet the Criteria for Insulin Pump Therapy
5. New Rhode Island Hospital study shows inadequate diagnostic criteria for eating disorders
6. Capital BlueCross CEO Says Meaningful Statewide Competition Must Be Key Criteria in Pennsylvanias Review of Proposed Highmark-IBC Merger
7. Landmark Articles Published by QualityMetric Scientists Report Improvements in Short Form Health Status Measures and Establish Criteria for Future Development
8. BMI criteria for obesity surgery should be lowered, UT Southwestern researchers suggest
9. Criteria Predict Womens 5-Year Risk for Fracture
10. New Test Criteria Spots Rheumatoid Arthritis Sooner
11. Health Care Leaders to Use New National Criteria for Patient-Centered Medical Home
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Oncology (ESMO), the leading pan-European organisation representing medical ... outstanding individuals receiving the Society,s esteemed annual awards. ... Heikki Joensuu and Peter Boyle on the occasion ... Spain. , Carsten Bokemeyer will receive the ESMO ... of cancer discovery into real benefit at patient ...
(Date:8/22/2014)... A new study finds a wide range of ... related to key environmental exposuresin children with Crohn,s disease (CD), ... of the Crohn,s & Colitis Foundation of America ... & Wilkins , a part of Wolters Kluwer Health ... alterations of DNA in several regions of the genome in ...
(Date:8/22/2014)... images of nurses at New York University,s Langone Medical ... many including the youngest and most vulnerable down flights ... storm surge generated by Hurricane Sandy. , Now, ... University Colleges of Nursing (NYUCN) and of Dentistry (NYUCD), ... examines the impact on NYULMC nurses, post-Sandy deployment to ...
(Date:8/22/2014)... Oldsmar, FL (PRWEB) August 22, 2014 ... Cryo-Cell’s cell therapy research affiliate, Saneron CCEL Therapeutics, Inc. ... agreement. , “Cryo-Cell is extremely pleased to collaborate with ... an IND, which we hope will lead to regenerative ... neurodegenerative diseases such as ALS,” David Portnoy, Chairman and ...
(Date:8/22/2014)... News) -- The U.S. Drug Enforcement Administration (DEA) is ... hydrocodone, which has been tied to a surge in ... restrictions would cover prescription narcotic drugs such as Vicodin, ... same regulatory class as painkillers such as Oxycontin, Percocet ... a three-month supply of the drug and will have ...
Breaking Medicine News(10 mins):Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3Health News:Study shows epigenetic changes in children with Crohn's disease 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 2Health News:Study identifies challenges faced by NYU nurses after Hurricane Sandy 3Health News:Cryo-Cell Provides Funding for Cord Blood Clinical Trial Application to Treat ALS 2Health News:Cryo-Cell Provides Funding for Cord Blood Clinical Trial Application to Treat ALS 3Health News:U.S. to Tighten Access to Certain Narcotic Painkillers 2Health News:U.S. to Tighten Access to Certain Narcotic Painkillers 3
... review investigating the effectiveness of a publicly funded graphic ... been associated with many negative outcomes. The review ... Science , a peer reviewed journal of the Society ... was created in 2005 to reduce methamphetamine use in ...
... or the "Company"), a leading provider of laser vision,correction services under the LasikPlus(R) ... stockholders in response to,recent letters from those stockholders to the Board. , ... Company,s Board of Directors appears,below: , , ... December ...
... Visit Atlantic City , , ATLANTIC CITY, ... who had been wounded in the Iraq conflict and recuperating at Walter ... a visit to Harrah,s Resorts in Atlantic City. , ... women, recovering , from war injuries and wishing for the ...
... N3 Oceanic, Inc. announced the addition of Orosine to ... cardiologist Dr. Jeffrey Shapiro, MD, Assistant Professor of Internal ... Langone Medical Center, who has been giving the formula to ... Dr. Shapiro states, Orosine is the most significant natural product ...
... Precision Optics,Corporation, Inc., (OTC Bulletin Board: POCI) ... the company,s common stock. Stockholders approved,the reverse split ... 2008. The,Board of Directors has determined that the ... Precision Optics Corporation and its stockholders, providing,the benefits ...
... are not being provided in Zimbabwe. The public health system ... Staggering inflation and unemployment have resulted in shortages of food ... of cholera, which is being spread by a shortage of ... date, the outbreak has claimed over 600 lives. , ...
Cached Medicine News:Health News:Success of anti-meth ads questioned by study 2Health News:Success of anti-meth ads questioned by study 3Health News:LCA-Vision Board of Directors Responds to Recent Letters from Stockholder Group 2Health News:LCA-Vision Board of Directors Responds to Recent Letters from Stockholder Group 3Health News:LCA-Vision Board of Directors Responds to Recent Letters from Stockholder Group 4Health News:Wounded Warriors to be Holiday Guests of Harrah's Entertainment 2Health News:Res-Q Gains Rights To Market Orosine - a Breakthrough, Patented, Natural Heart Supplement That Cardiologists Are Calling the 'Ultimate Cardio Protection' Against Heart Attacks, Strokes and Heart Failure. 2Health News:Precision Optics Corporation to Effect Reverse Split and Ticker Symbol Change 2
(Date:8/21/2014)... , Aug. 21, 2014  Vermillion, Inc. (NASDAQ: ... gynecologic cancers and women,s health, has appointed Holly ... Managed Markets. Ms. Bauzon has a proven ... payer coverage for laboratory services companies. She has more ... PerkinElmer, Inc., where she held the position of Director, ...
(Date:8/21/2014)... , Aug. 21, 2014  eRelevance Corporation ... company, announced today that it has completed integration ... solution for Plastic Surgery and Dermatology practices. ... more value to healthcare practices using Nextech," stated ... eRelevance Corporation. "Using information from the EMR we ...
(Date:8/21/2014)... 21, 2014  Publicis Groupe customer engagement agency ... Partner and Healthcare Industry Group Leader, has been featured ... the most inspiring people in the life-sciences industry. Those ... and development, marketing, technology, creativity, strategy and medicine. ... a partner in its leading Rosetta Consulting practice. In ...
Breaking Medicine Technology:Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Shannon Hartley Shines in PharmaVOICE 100 2
... Medical is the world leader in ... used worldwide for permanent pacemaker and ... and port implantation, and for temporary ... St. Jude Medical Peel-Away introducers includes ...
... Self-Expanding Stent System combines low-profile, high radial force, ... guide wire compatible stent system provides 6F sheath ... (5.0 - 10.0 mm). Now, with longer stents ... five stent lengths (28, 38, 56, 80 and ...
... A particular challenge in transseptal left heart ... must be exchanged for a sheath with ... wall position. Traditionally, such an exchange has ... heparinized patient. Biosense Webster has overcome this ...
Coaxial Multicolor LIO Worlds first coaxial multicolor LIO provides precise laser delivery with repeatable outcomes, as well as maximum treatment options and physician safety....
Medicine Products: